Content area
Abstract
The isotopic labelling of small molecules is integral to drug development and for understanding biochemical processes. The preparation of carbon-labelled α-amino acids remains difficult and time consuming, with established methods involving label incorporation at an early stage of synthesis. This explains the high cost and scarcity of C-labelled products and presents a major challenge in 11C applications (11C t1/2 = 20 min). Here we report that aldehydes catalyse the isotopic carboxylate exchange of native α-amino acids with *CO2 (* = 14, 13, 11). Proteinogenic α-amino acids and many non-natural variants containing diverse functional groups undergo labelling. The reaction probably proceeds via the trapping of *CO2 by imine-carboxylate intermediates to generate iminomalonates that are prone to monodecarboxylation. Tempering catalyst electrophilicity was key to preventing irreversible aldehyde consumption. The pre-generation of the imine carboxylate intermediate allows for the rapid and late-stage 11C-radiolabelling of α-amino acids in the presence of [11C]CO2.
Carbon-labelled α-amino acids are valuable compounds in drug development and nuclear medicine, but are difficult and time consuming to prepare. Now, an aldehyde-catalysed method has been developed for the direct C1-labelling of α-amino acids using *CO2 (* = 14, 13, 11), providing access to many proteinogenic and non-natural labelled α-amino acids.
Details
; Munch, Maxime 2
; Mair, Braeden A. 2
; Cooze, Christopher J. C. 1 ; Derdau, Volker 3
; Bauer, Armin 3 ; Kong, Duanyang 1 ; Rotstein, Benjamin H. 2
; Lundgren, Rylan J. 1
1 University of Alberta, Department of Chemistry, Edmonton, Canada (GRID:grid.17089.37)
2 University of Ottawa, Department of Biochemistry, Microbiology and Immunology and Department of Chemistry and Biomolecular Sciences, Ottawa, Canada (GRID:grid.28046.38) (ISNI:0000 0001 2182 2255); University of Ottawa Heart Institute, Ottawa, Canada (GRID:grid.28046.38) (ISNI:0000 0001 2182 2255)
3 Sanofi-Aventis Deutschland GmbH, R&D, Integrated Drug Discovery, Isotope Chemistry, Industriepark Höchst, Frankfurt, Germany (GRID:grid.420214.1)





